Delivery Order SPE2DB22D3501-SPE2DB24FWG60

Award Date 7/15/24
Potential Completion Date 8/5/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $6,168.26 and has a completion date of February 24, 2025. It is for the delivery of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $33,409.40 fixed-price delivery order is for the supply of Hemlibra 150 mg/mL vials, a specialty pharmaceutical product. The contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,409.40 firm fixed-price delivery order is for Hemlibra 150 mg/mL vial, a specialty medication. It has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with an ID of SPE2DB22D3301|SPE2DB25FX4KD, was issued by the Defense Logistics Agency (DLA) for the delivery of HEMLIBRA 150 MG/ML VIALML, a specialty pharmaceutical product. The $16,704.72 firm-fixed-price delivery order has an ultimate completion date of November 18, 2024 and was awarded on October 25, 2024 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside for any specific business...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the purchase of HEMLIBRA 150 MG/ML vials. The delivery order has a ceiling value of $16,704.72 and is a firm-fixed price contract, with an ultimate completion date of September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of essential medical commodities, including specialty medications, brand-name and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $23,330.40 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,565,282 units of the specialty pharmaceutical product Hemlibra (105 mg/0.7 ml vial). The contract has an ultimate completion date of August 19, 2024 and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $16,704.72 firm-fixed-price delivery order is for the supply of Hemlibra, a prescription medication, with a completion date of September 10, 2024. This award does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite-delivery contracts (IDCs) with DLA and other federal agencies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,451.35 firm fixed price delivery order is for the supply of Heparin 25,000 unit/250 mL-D5W 250 mL medical products. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $25,150.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, valued at $11,350.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWG60
    Delivery Order

This federal contract award, valued at $16,704.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HEMLIBRA 150 MG/ML VIALML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 5, 2024.

Amerisourcebergen Drug Corp, through its Corporate Office Division, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, the company holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract is not designated as a set-aside.

Generated 10/14/24, 10:24 AM